SonoScape Medical Corp. (SHE:300633)
China · Delayed Price · Currency is CNY 19.02
+0.12 (0.63%)
Jun 24, 2026, 3:04 PM CST
SonoScape Medical Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, SonoScape Medical stock has a consensus rating of "Buy" and an average price target of ¥34.28. The average 1-year stock price forecast is 80.23% higher than the current stock price, while the lowest is ¥29.90 (+57.20%) and the highest is ¥37.15 (+95.32%).
Price Target: ¥34.28 (+80.23%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SonoScape Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 6 | 6 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 9 | 9 | 7 | 7 |
Financial Forecast
Revenue This Year
2.67B
from 2.31B
Increased by 15.49%
Revenue Next Year
2.98B
from 2.67B
Increased by 11.94%
EPS This Year
5.39
from 2.86
Increased by 88.10%
EPS Next Year
6.77
from 5.39
Increased by 25.75%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.7B | ||
| Avg | 2.7B | ||
| Low | 2.7B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 16.4% | ||
| Avg | 15.5% | ||
| Low | 14.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.66 | ||
| Avg | 5.39 | ||
| Low | 5.11 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 97.6% | ||
| Avg | 88.1% | ||
| Low | 78.6% |